Submitted by Anonymous (not verified) on 28 August 2025 - 9:41
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 13, Status: Authorised